InVivo Therapeutics Holdings Price to Book Ratio 2010-2023 | NVIVQ
Historical price to book ratio values for InVivo Therapeutics Holdings (NVIVQ) over the last 10 years. The current price to book ratio for InVivo Therapeutics Holdings as of June 04, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| InVivo Therapeutics Holdings Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2024-07-19 | 0.37 | 0.13 | |
| 2023-09-30 | 1.12 | $2.87 | 0.39 |
| 2023-06-30 | 1.35 | $3.73 | 0.36 |
| 2023-03-31 | 1.06 | $4.34 | 0.24 |
| 2022-12-31 | 2.35 | $6.48 | 0.36 |
| 2022-09-30 | 4.29 | $7.26 | 0.59 |
| 2022-06-30 | 4.05 | $9.21 | 0.44 |
| 2022-03-31 | 8.75 | $11.32 | 0.77 |
| 2021-12-31 | 11.50 | $13.21 | 0.87 |
| 2021-09-30 | 17.50 | $15.28 | 1.15 |
| 2021-06-30 | 18.50 | $17.01 | 1.09 |
| 2021-03-31 | 24.75 | $18.62 | 1.33 |
| 2020-12-31 | 20.25 | $20.30 | 1.00 |
| 2020-09-30 | 35.50 | $39.98 | 0.89 |
| 2020-06-30 | 39.50 | $51.36 | 0.77 |
| 2020-03-31 | 42.25 | $92.92 | 0.45 |
| 2019-12-31 | 165.00 | $253.31 | 0.65 |
| 2019-09-30 | 375.00 | $619.61 | 0.61 |
| 2019-06-30 | 555.00 | $843.95 | 0.66 |
| 2019-03-31 | 1162.50 | $1,092.06 | 1.06 |
| 2018-12-31 | 1132.50 | $1,299.27 | 0.87 |
| 2018-09-30 | 1515.00 | $1,631.05 | 0.93 |
| 2018-06-30 | 1275.00 | $-351.44 | -3.63 |
| 2018-03-31 | 10125.00 | $4,000.32 | 2.53 |
| 2017-12-31 | 14437.50 | $7.38 | 1955.88 |
| 2017-09-30 | 27187.50 | $0.42 | 65244.78 |
| 2017-06-30 | 50625.00 | $0.59 | 85790.54 |
| 2017-03-31 | 75937.50 | $0.75 | 101670.24 |
| 2016-12-31 | 78750.00 | $0.90 | 87083.93 |
| 2016-09-30 | 127500.00 | $1.03 | 124244.79 |
| 2016-06-30 | 108375.00 | $1.18 | 91874.36 |
| 2016-03-31 | 130875.00 | $1.30 | 100526.15 |
| 2015-12-31 | 135000.00 | $0.62 | 219512.20 |
| 2015-09-30 | 161625.00 | $0.63 | 255857.21 |
| 2015-06-30 | 302812.00 | $0.59 | 513851.18 |
| 2015-03-31 | 222750.00 | $0.39 | 564209.73 |
| 2014-12-31 | 99000.00 | $0.25 | 391923.99 |
| 2014-09-30 | 42000.00 | $0.15 | 289655.17 |
| 2014-06-30 | 78000.00 | $0.15 | 519307.59 |
| 2014-03-31 | 132000.00 | $0.11 | 1149825.78 |
| 2013-12-31 | 172500.00 | $0.16 | 1053113.55 |
| 2013-09-30 | 107250.00 | $0.22 | 479436.75 |
| 2013-06-30 | 309750.00 | $0.29 | 1085318.85 |
| 2013-03-31 | 179250.00 | $-0.22 | -826798.89 |
| 2012-12-31 | 130500.00 | $-0.04 | -3717948.72 |
| 2012-09-30 | 116250.00 | $0.08 | 1388888.89 |
| 2012-06-30 | 171750.00 | $-0.07 | -2349521.20 |
| 2012-03-31 | 186000.00 | $-0.13 | -1404833.84 |
| 2011-12-31 | 206250.00 | $-0.58 | -355480.87 |
| 2011-09-30 | 49500.00 | $-0.01 | -4342105.26 |
| 2011-06-30 | 74250.00 | $-0.08 | -978260.87 |
| 2011-03-31 | 63750.00 | $-0.06 | -1089743.59 |
| 2010-12-31 | 168750.00 | $-0.04 | -4700557.10 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.000B | $0.000B |
| InVivo Therapeutics Holdings Corp. operates as a medical device company focused on utilizing polymers as a platform technology to develop treatments to improve function in individuals paralyzed as a result of traumatic spinal cord injury. The company intends to offer three products, including a biocompatible polymer scaffolding device to treat acute wound SCI; a biocompatible hydrogel for local controlled release of methylprednisolone to treat acute SCI; and a biocompatible polymer scaffolding device seeded with autologous hNSCs to treat acute and chronic SCI. InVivo Therapeutics Holdings Corp. is based in Cambridge, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $232.634B | 27.97 |
| Boston Scientific (BSX) | United States | $152.531B | 38.19 |
| Stryker (SYK) | United States | $145.427B | 30.41 |
| EssilorLuxottica (ESLOY) | France | $127.535B | 0.00 |
| Medtronic (MDT) | Ireland | $109.709B | 15.55 |
| Haleon (HLN) | United Kingdom | $49.754B | 28.33 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.468B | 0.00 |
| ResMed (RMD) | United States | $36.224B | 27.21 |
| GE HealthCare Technologies (GEHC) | United States | $32.583B | 15.47 |
| Agilent Technologies (A) | United States | $32.148B | 20.88 |
| Terumo (TRUMY) | Japan | $26.857B | 34.88 |
| Insulet (PODD) | United States | $22.748B | 89.29 |
| Koninklijke Philips (PHG) | Netherlands | $21.431B | 15.40 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.172B | 11.67 |
| Baxter (BAX) | United States | $15.441B | 11.53 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.754B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.002B | 20.89 |
| Lantheus Holdings (LNTH) | United States | $5.375B | 13.56 |
| Prestige Consumer Healthcare (PBH) | United States | $4.194B | 18.74 |
| Perrigo (PRGO) | Ireland | $3.646B | 9.24 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.346B | 15.24 |
| ICU Medical (ICUI) | United States | $3.213B | 23.69 |
| Envista Holdings (NVST) | United States | $3.174B | 26.38 |
| GN Store Nord (GNNDY) | Denmark | $2.155B | 17.85 |
| QuidelOrtho (QDEL) | United States | $2.048B | 14.09 |
| LeMaitre Vascular (LMAT) | United States | $1.872B | 41.85 |
| AtriCure (ATRC) | United States | $1.719B | 0.00 |
| Neogen (NEOG) | United States | $1.302B | 16.67 |
| Acuren (TIC) | United States | $1.300B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.196B | 12.14 |
| Green Thumb Industries (GTBIF) | United States | $1.110B | 24.97 |
| BioLife Solutions (BLFS) | United States | $1.016B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.008B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.986B | 12.60 |
| InMode (INMD) | Israel | $0.930B | 9.37 |
| Evolus (EOLS) | United States | $0.642B | 0.00 |
| CeriBell (CBLL) | United States | $0.612B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.565B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.544B | 0.00 |
| Valneva SE (VALN) | France | $0.519B | 0.00 |
| Owens & Minor (OMI) | United States | $0.517B | 4.29 |
| Capricor Therapeutics (CAPR) | United States | $0.509B | 0.00 |
| Surmodics (SRDX) | United States | $0.422B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.403B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.366B | 0.00 |
| SNDL (SNDL) | Canada | $0.336B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.326B | 11.98 |
| Aurora Cannabis (ACB) | Canada | $0.302B | 53.70 |
| Cresco Labs (CRLBF) | United States | $0.277B | 0.00 |
| Cerus (CERS) | United States | $0.275B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.268B | 22.63 |
| Sanara MedTech (SMTI) | United States | $0.259B | 0.00 |
| ZimVie (ZIMV) | United States | $0.258B | 11.75 |
| Sanuwave Health (SNWV) | United States | $0.242B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.222B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.221B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.216B | 0.00 |
| Quanterix (QTRX) | United States | $0.211B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.196B | 0.00 |
| Biote (BTMD) | United States | $0.194B | 5.46 |
| Brainsway (BWAY) | Israel | $0.192B | 50.95 |
| High Tide (HITI) | Canada | $0.185B | 0.00 |
| Omeros (OMER) | United States | $0.184B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.182B | 14.81 |
| Organigram Global (OGI) | Canada | $0.178B | 0.00 |
| Exagen (XGN) | United States | $0.157B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.139B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.135B | 16.58 |
| Jin Medical (ZJYL) | China | $0.122B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.098B | 0.00 |
| MacroGenics (MGNX) | United States | $0.095B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
| Veru (VERU) | United States | $0.090B | 0.00 |
| Fonar (FONR) | United States | $0.090B | 11.62 |
| Agape ATP (ATPC) | $0.081B | 0.00 | |
| Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
| InterCure (INCR) | Israel | $0.070B | 0.00 |
| Zynex (ZYXI) | United States | $0.065B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.062B | 0.00 |
| Apyx Medical (APYX) | United States | $0.061B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.057B | 0.00 |
| Modular Medical (MODD) | United States | $0.048B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.94 |
| Nephros (NEPH) | United States | $0.035B | 46.71 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| Safety Shot (SHOT) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |